Page last updated: 2024-08-23

amikacin and fosfomycin

amikacin has been researched along with fosfomycin in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (12.50)	18.7374
1990's	5 (10.42)	18.2507
2000's	4 (8.33)	29.6817
2010's	24 (50.00)	24.3611
2020's	9 (18.75)	2.80

Authors

Authors	Studies
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Blango, MG; Mulvey, MA	1
Blázquez, J; Couce, A; Rodríguez-Rojas, A	1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bastin, R; Charmot, G; Frottier, J	1
Kasatkina, IV; Makarovskaia, LN; Shcherbaniuk, AI	1
Amprimo, MC; Caramalli, S; Cavalli, G; Franchino, L; Mantelli, M; Pollastrelli, E; Raiteri, F; Varese, LA	1
Hotta, T; Kagami, Y; Mitomo, Y; Mizuno, H; Murate, T; Nitta, M; Ohnishi, K; Ohno, R; Saito, H; Yamao, H	1
Debbia, E; Pesce, A; Schito, GC	1
Chaste, A; Combremont, AG; David, C; Saison, C	1
Aso, Y; Fujita, HM; Fujita, K	1
Fujita, K	1
Schrettenbrunner, A; Schröter, G	1
Martinez-Martinez, L; Pascual, A; Perea, EJ; Rodriguez, G; Suárez, AI	1
Quentin, C; Tessier, F	1
Brinkmann, G; Hellwege, HH; Kaczmarek, D; Kammler, G; Sonntag, J	1
Abid, F; Ali Lachtar, M; Ayadi, A; Bedoui, A; Ben Homouda, H; Boussoffara, R; Braham, M; Mahjoub, B; Methlouthi, J; Sfar, MT	1
Falagas, ME; Gkegkes, ID; Kastoris, AC; Rafailidis, PI; Vouloumanou, EK	1
Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H	1
Burian, A; Erdogan, Z; Jandrisits, C; Zeitlinger, M	1
Athanasiou, S; Falagas, ME; Tansarli, GS	1
Abuan, T; Davies, A; Montgomery, AB; Tservistas, M; Vallance, S	1
Abuan, T; Flamm, RK; Montgomery, AB; Rhomberg, PR; Walters, KA	2
Conejo, MC; Domínguez, MC; Pascual, Á; Rodríguez-Baño, J; Vergara-López, S	1
Chen, PY; Chien, YL; Chou, CM; Fu, LS; Huang, CM; Huang, FL; Lin, CF; Wu, TH	1
Graves, B; Hajkowicz, K; Paterson, DL; Stewart, A; Ta, K	1
Gil-Romero, Y; Gómez-Garcés, JL; Merino, F; Vazquez, O	1
Boulain, T; Danker, W; Dimopoulos, G; Francois, B; Garot, D; Ischaki, E; Ivanyi, Z; János, G; Kollef, MH; Koura, F; Montgomery, AB; Ricard, JD; Roux, D; Rozgonyi, Z; Torres, A; Zakynthinos, E	1
Aires, CA; Albano, RM; Asensi, MD; Buonora, SN; Carvalho-Assef, AP; Chagas, TP; de Araujo, CF; Oliveira, JC; Pereira, PS	1
Shorr, AF; Zilberberg, MD	1
Chatsuwan, T; Singkham-In, U	1
Bueno, MFC; Camargo, CH; Cury, AP; David-Neto, E; de Oliveira Garcia, D; de Paula, FJ; Dos Santos, NF; Francisco, GR; Freire, MP; Nahas, WC; Pierrotti, LC; Rossi, F; Spadão, F	1
Aguilera Xiol, E; Amaro, R; Antonelli, M; Artigas, A; Blasi, F; Bobi, J; Bringué, J; Carbonara, M; Chiurazzi, C; Comaru, T; Comino Trinidad, O; De Rosa, F; Fernandez-Barat, L; Fuster, C; Li Bassi, G; Marti, JD; Montgomery, AB; Motos, A; Nicolau, DP; Pelosi, P; Ramirez, J; Ranzani, OT; Rigol, M; Rinaudo, M; Saco, MA; Senussi, T; Torres, A; Yang, H	1
Gilbert, DN	1
Mandal, J; Sugathan, S	1
Avery, LM; Mullane, EM; Nicolau, DP	1
Dobashi, M; Ikeda, M; Ishii, J; Koguchi, D; Murakami, Y	1
Hua, X; Moran, RA; Sun, L; van Schaik, W; Xu, Q; Yu, Y; Zhang, L	1
Altun, B; Cakar, A; Demirci-Duarte, S; Eser, OK; Gur, D; Sancak, B; Unalan-Altintop, T	1
Chatsuwan, T; Muhummudaree, N; Singkham-In, U	1
Bostrom, MP; Carli, AV; Levack, AE; Miller, AO; Turajane, K; Wellman, DS; Yang, X	1
Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E	1
Ahmad, S; Ahmed, S; Ali, F; Farooq, M; Haq, I; Qureshi, SA; Rasheed, A; Sabir, MS; Shakeela, Q; Uzma, B	1
Chung, HS; Hwang, EC; Jung, SI; Kim, MS; Kwon, DD; Ryu, JW; Yu, SH	1

Reviews

4 review(s) available for amikacin and fosfomycin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
[Infectious and parasitic diseases. Survey of the current status in 1977]. La Revue du praticien, 1977, May-21, Volume: 27, Issue:29 Topics: Amikacin; Anemia, Sickle Cell; Animals; Anti-Bacterial Agents; Azepines; Burkitt Lymphoma; Fosfomycin; Hepatitis, Viral, Human; Herpesvirus 4, Human; Humans; Lassa Fever; Liver; Malaria; Marburg Virus Disease; Oxamniquine; Parasitic Diseases; Penicillanic Acid; Pneumonia, Pneumocystis; Smallpox; Ticarcillin; Trichinellosis; Vaccination; Virus Diseases	1977
Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8 Topics: Africa; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Databases, Factual; Drug Evaluation; Enterobacteriaceae; Enterobacteriaceae Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections	2013
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. International journal of antimicrobial agents, 2021, Volume: 57, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin	2021

Trials

4 trial(s) available for amikacin and fosfomycin

Article	Year
Effect and pharmacokinetics of netilmicin given as bolus intramuscular administration: an open comparative trial versus amikacin and fosfomycin in elderly patients affected by urinary tract infections. International journal of clinical pharmacology research, 1991, Volume: 11, Issue:2 Topics: Age Factors; Aged; Algorithms; Amikacin; Female; Fosfomycin; Humans; Injections, Intramuscular; Male; Middle Aged; Netilmicin; Urinary Tract Infections; Urine	1991
[Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders]. The Japanese journal of antibiotics, 1990, Volume: 43, Issue:12 Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cephamycins; Clindamycin; Drug Therapy, Combination; Female; Fosfomycin; Hematologic Diseases; Humans; Male	1990
A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients. Journal of aerosol medicine and pulmonary drug delivery, 2014, Volume: 27, Issue:6 Topics: Administration, Inhalation; Adult; Aerosols; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Double-Blind Method; Drug Combinations; Drug Monitoring; Equipment Design; Fosfomycin; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Ventilator-Associated; Respiration, Artificial; Tracheitis; Victoria	2014
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS Trial. Chest, 2017, Volume: 151, Issue:6 Topics: Administration, Inhalation; Adult; Aged; Amikacin; Anti-Bacterial Agents; APACHE; Chemotherapy, Adjuvant; Double-Blind Method; Female; Fosfomycin; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Treatment Outcome	2017

Other Studies

40 other study(ies) available for amikacin and fosfomycin

Article	Year
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms. Journal of medicinal chemistry, 2007, Aug-23, Volume: 50, Issue:17 Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium	2010
Frequency of spontaneous resistance to fosfomycin combined with different antibiotics in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11 Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fosfomycin; Mutation; Pseudomonas aeruginosa	2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction	2010
[Effectiveness of phosphomycin and its combinations with amikacin and cefotaxime in experimental plague infection]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1992, Volume: 37, Issue:11 Topics: Amikacin; Animals; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Injections, Intramuscular; Mice; Plague	1992
In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci. The Journal of hospital infection, 1986, Volume: 7 Suppl A Topics: Amikacin; Anti-Bacterial Agents; Drug Interactions; Fosfomycin; Glycopeptides; Humans; Imipenem; Netilmicin; Rifampin; Staphylococcus; Streptococcus; Teicoplanin; Thienamycins	1986
[In vitro effect of combinations of netilmicin and amikacin with fosfomycin and pefloxacin on 31 strains of heterogeneous methicillin- resistant Staphylococcus aureus]. Pathologie-biologie, 1988, Volume: 36, Issue:5 Pt 2 Topics: Amikacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; In Vitro Techniques; Methicillin; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Staphylococcal Infections; Staphylococcus aureus	1988
[Protective effect of fosfomycin against renal accumulation of aminoglycoside antibiotics]. The Japanese journal of antibiotics, 1983, Volume: 36, Issue:12 Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Fosfomycin; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred Strains	1983
An effect of fosfomycin on the pharmacokinetics of amikacin. The Journal of antibiotics, 1984, Volume: 37, Issue:4 Topics: Amikacin; Animals; Anti-Bacterial Agents; Drug Interactions; Fosfomycin; Intestinal Absorption; Kanamycin; Kidney; Kinetics; Lysosomes; Male; Rats; Rats, Inbred Strains	1984
[Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa]. Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious..., 1982, Volume: 253, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Antagonism; Drug Synergism; Fosfomycin; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins	1982
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:6 Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin	1996
In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997, Volume: 16, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins	1997
[Complicating neonatal Escherichia coli meningitis]. Zeitschrift fur Geburtshilfe und Neonatologie, 2004, Volume: 208, Issue:1 Topics: Amikacin; Brain; Drug Therapy, Combination; Echoencephalography; Empyema, Subdural; Escherichia coli Infections; Female; Fosfomycin; Humans; Infant, Newborn; Intensive Care, Neonatal; Magnetic Resonance Imaging; Meningitis, Escherichia coli; Meropenem; Microbial Sensitivity Tests; Patient Care Team; Thienamycins; Treatment Outcome	2004
[Severe community acquired pneumonia due to Staphylococcus aureus in children. About two cases]. La Tunisie medicale, 2006, Volume: 84, Issue:10 Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Community-Acquired Infections; Female; Follow-Up Studies; Fosfomycin; Humans; Pneumonia, Staphylococcal; Radiography, Thoracic; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2006
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. European journal of clinical pharmacology, 2010, Volume: 66, Issue:4 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fosfomycin; Gentamicins; Gram-Negative Bacteria; Methicillin Resistance	2010
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult	2011
Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine. Pharmacology, 2012, Volume: 90, Issue:5-6 Topics: Amikacin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Colistin; Ertapenem; Fosfomycin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Trimethoprim; Urine	2012
Potentiation effects of amikacin and fosfomycin against selected amikacin-nonsusceptible Gram-negative respiratory tract pathogens. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:7 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections	2014
Amikacin-fosfomycin at a five-to-two ratio: characterization of mutation rates in microbial strains causing ventilator-associated pneumonia and interactions with commonly used antibiotics. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:7 Topics: Amikacin; Anti-Bacterial Agents; Bacteria; DNA Mutational Analysis; Drug Combinations; Drug Interactions; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Kinetics; Microbial Sensitivity Tests; Mutation; Pneumonia, Ventilator-Associated	2014
Prolonged treatment with large doses of fosfomycin plus vancomycin and amikacin in a case of bacteraemia due to methicillin-resistant Staphylococcus epidermidis and IMP-8 metallo-β-lactamase-producing Klebsiella oxytoca. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:1 Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Coinfection; Fosfomycin; Humans; Klebsiella Infections; Klebsiella oxytoca; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin	2015
Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:5 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftazidime; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Infant; Male; Pilot Projects; Recurrence; Retrospective Studies; Taiwan; Urinary Tract Infections; Vesico-Ureteral Reflux	2016
The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter Osteomyelitis. Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Meropenem; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus epidermidis; Thienamycins	2015
[Synergistic activity and clinical efficacy of fosfomycin and ciprofloxacin combination treatment for soft tissue infection caused by carbapenemase-producing Enterobacter cloacae]. Enfermedades infecciosas y microbiologia clinica, 2017, Volume: 35, Issue:2 Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Colonic Diseases; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fosfomycin; Hernia, Abdominal; Herniorrhaphy; Humans; Intestinal Fistula; Minocycline; Postoperative Complications; Prosthesis-Related Infections; Soft Tissue Infections; Surgical Mesh; Tigecycline	2017
Multiclonal Expansion of Klebsiella pneumoniae Isolates Producing NDM-1 in Rio de Janeiro, Brazil. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Brazil; Clone Cells; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fosfomycin; Gene Expression; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Multilocus Sequence Typing; Phylogeny; Plasmids; Polymyxin B; Tigecycline	2017
The Answer for Inhaled Antibiotics in Pneumonia Is Still Blowing in the Wind. Chest, 2017, Volume: 151, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Fosfomycin; Humans; Pneumonia, Ventilator-Associated; Ventilators, Mechanical	2017
In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates. Diagnostic microbiology and infectious disease, 2018, Volume: 91, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Fosfomycin; Humans; Microbial Sensitivity Tests; Thailand	2018
The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019, Volume: 38, Issue:4 Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Fosfomycin; Humans; Kidney Transplantation; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxins; Retrospective Studies; Risk Factors; Transplant Recipients; Treatment Failure; Treatment Outcome	2019
Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study. Critical care medicine, 2019, Volume: 47, Issue:6 Topics: Administration, Inhalation; Administration, Intravenous; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Lung; Meropenem; Nebulizers and Vaporizers; Pneumonia; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Swine; Trachea	2019
Nebulized Antibiotics for Multidrug-Resistant Ventilator-Associated Pseudomonas aeruginosa Pneumonia. Critical care medicine, 2019, Volume: 47, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Fosfomycin; Humans; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections	2019
An Journal of medical microbiology, 2019, Volume: 68, Issue:12 Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Synergism; Escherichia coli; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Urinary Tract Infections	2019
Comparative Evaluation of the Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Cephalosporins; Cyclooctanes; Drug Resistance, Multiple, Bacterial; Fosfomycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2020
Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study. BMC urology, 2020, Apr-06, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Cefaclor; Cefazolin; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Fosfomycin; Humans; Klebsiella Infections; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult	2020
Cointegration as a mechanism for the evolution of a KPC-producing multidrug resistance plasmid in Emerging microbes & infections, 2020, Volume: 9, Issue:1 Topics: Amikacin; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Evolution, Molecular; Female; Fosfomycin; Genetic Fitness; Genome Size; High-Throughput Nucleotide Sequencing; Humans; Male; Middle Aged; Plasmids; Proteus mirabilis; Sputum; Whole Genome Sequencing	2020
Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant. Diagnostic microbiology and infectious disease, 2020, Volume: 98, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Urinary Tract Infections; Virulence Factors	2020
fosA3 overexpression with transporter mutations mediates high-level of fosfomycin resistance and silence of fosA3 in fosfomycin-susceptible Klebsiella pneumoniae producing carbapenemase clinical isolates. PloS one, 2020, Volume: 15, Issue:8 Topics: Amikacin; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Membrane Transport Proteins; Microbial Sensitivity Tests; Plasmids; RNA, Messenger	2020
Thermal Stability and in Vitro Elution Kinetics of Alternative Antibiotics in Polymethylmethacrylate (PMMA) Bone Cement. The Journal of bone and joint surgery. American volume, 2021, 09-15, Volume: 103, Issue:18 Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Bone Cements; Drug Stability; Fosfomycin; Kinetics; Meropenem; Microbial Sensitivity Tests; Polymethyl Methacrylate; Prosthesis-Related Infections; Staphylococcus aureus; Tobramycin	2021
The evaluation of antibiotic susceptibility pattern and associated risk factors of UTI in tertiary care hospital of Peshawar. Pakistan journal of pharmaceutical sciences, 2022, Volume: 35, Issue:3(Special) Topics: Amikacin; Anti-Bacterial Agents; Escherichia coli; Female; Fosfomycin; Humans; Imipenem; Klebsiella pneumoniae; Linezolid; Male; Meropenem; Pseudomonas aeruginosa; Risk Factors; Tertiary Care Centers; Urinary Tract Infections; Vancomycin	2022
Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study. Investigative and clinical urology, 2022, Volume: 63, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Ciprofloxacin; Fluoroquinolones; Fosfomycin; Humans; Male; Prostate; Retrospective Studies	2022